Showing 121-130 of 5352 results for "".
The Shape of the Contouring Market: Expert Tips on Energy-based Body Treatments
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-shape-of-the-contouring-market-expert-tips-on-energy-based-body-treatments/20332/Experienced clinicians weigh in on their approach to identifying, educating, and treating patients for body contouring.Skin Cancer Awareness, Epiduo Data, Impoyz Launch
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-skin-cancer-awareness-epiduo-data-impoyz-launch/18307/Data shed light on patents' attitudes towards kids' sunblock and new findings emerge on melanoma risks. FDA accepts BLA for cemiplimab for advanced SCC and approves Novartis' Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutationsExpectations: Put it in Writing
https://practicaldermatology.com/topics/practice-management/expectations-put-it-in-writing/20521/Patients who have clear expectations and understand their role in their care and treatment are more engaged, more compliant, and are more likely to have better outcomes. It helps to get it in writing.What's your Mobile Engagement Quotient?
https://practicaldermatology.com/topics/practice-management/meq/18486/Do you know your mobile engagement quotient? Do you even know what MEQ is? To connect with and expand your patient base, you need to enhance mobile engagement. Learn what you need to know in this Ekwa.com Marketing Educational video.Heart of the Matter: Effects of Psoriasis Treatment on CV Risks
https://practicaldermatology.com/topics/psoriasis/heart-of-the-matter-effects-of-psoriasis-treatment-on-cv-risks/18747/By Jashin Wu, MD and Seemal R. Desai, MDThere's growing evidence that treatment of psoriasis reduces the risk of CV events, but it's not clear whether this potential benefit should influence treatment decisions. Patient screening and counseling remain important, Dr. Wu says.What Do You Expect?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/what-do-you-expect/18751/By Emmy Graber, MD and Seemal R. Desai, MDDo you always show prospective patients your best photos? Sometimes it's good to show the average result. Dr. Graber discusses this and other aspects of expectation management for cosmetic interventions.Laser Advice for Early Adopters
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/laser-advice-for-early-adopters/18809/“Fat melting is not a passing phase,” says Amy Forman Taub, MD. The technology is in its infancy, but applications will expand, she says. Dr. Taub, a laser and device expert offers suggestions on evaluating and choosing devices for a cosmetic practice. GenerationsMelanoma Treatment Landscape Evolves
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-treatment-landscape-evolves/21314/The first agent to target the PD-1 pathway, pembrolizumab may prolong life expectancy in some patients.Eight Essential SEO Checkpoints for Your Practice Website
https://practicaldermatology.com/topics/practice-management/eight-essential-seo-checkpoints-for-your-practice-website/21466/Close attention to these critical checkpoints will ensure that your website's SEO performance is sustainable.Clinical Case Report: Severe Allergic Contact Dermatitis of Eyelids: When Topical and Oral Steroids Are Not an Option
https://practicaldermatology.com/topics/general-topics/clinical-case-report-severe-allergic-contact-dermatitis-of-eyelids-when-topical-and-oral-steroids-are-not-an-option/21878/Topical calcineurin inhibitors may present a therapeutic option for contact dermatitis of the eyelids.